APO RESEARCH · REPORT
Tigecycline
Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.
Product & engineering
Understand the product.
Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.
Selected research
Industry Research
Tigecycline Industry Research Report 2026
Market perspective
Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.
Global Tigecycline Sales Channel is wide, like Hospital Pharmacies , Retail Pharmacies. Hospital Pharmacies is the largest consumer channel.
Tigecycline can be mainly divided into Generic Drug, Original Drug.
Read the full market overview
In 2019, North America dominated the global Tigecycline market, accounting for more than 34% of the total revenue.
Report Scope
This report quantifies the global Tigecycline market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tigecycline Market by Company
Pfizer (Wyeth)
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Jiangsu Hansoh Pharmaceutical
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz
APOTEX
Accord Healthcare
Amneal Pharmaceuticals
Tigecycline Segment by Type
Original Drug
Generic Drug
Tigecycline Segment by Application
Hospital Pharmacies
Retail Pharmacies
Tigecycline Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tigecycline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tigecycline and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tigecycline.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tigecycline manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tigecycline by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tigecycline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drug
- Generic Drug
Applications
- Hospital Pharmacies
- Retail Pharmacies
Companies covered
- Pfizer (Wyeth)
- Sino Biopharmaceutical
- Zhejiang Hisun Pharma
- Jiangsu Hansoh Pharmaceutical
- Abbott
- Natco Pharma
- Lyka Labs Limited
- Fresenius Kabi
- Sandoz
- APOTEX
- Accord Healthcare
- Amneal Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tigecycline Market Size (2021-2032)
- 2.2.2 Global Tigecycline Sales (2021-2032)
- 2.2.3 Global Tigecycline Market Average Price (2021-2032)
- 2.3 Tigecycline by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Original Drug
- 2.3.3 Generic Drug
- 2.4 Tigecycline by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tigecycline Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tigecycline Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Tigecycline Revenue of Manufacturers (2021-2026)
- 3.4 Global Tigecycline Average Price by Manufacturers (2021-2026)
- 3.5 Global Tigecycline Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tigecycline, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tigecycline, Product Type & Application
- 3.8 Global Manufacturers of Tigecycline, Established Date
- 3.9 Global Tigecycline Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer (Wyeth)
- 4.1.1 Pfizer (Wyeth) Company Information
- 4.1.2 Pfizer (Wyeth) Business Overview
- 4.1.3 Pfizer (Wyeth) Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer (Wyeth) Tigecycline Product Portfolio
- 4.1.5 Pfizer (Wyeth) Recent Developments
- 4.2 Sino Biopharmaceutical
- 4.2.1 Sino Biopharmaceutical Company Information
- 4.2.2 Sino Biopharmaceutical Business Overview
- 4.2.3 Sino Biopharmaceutical Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sino Biopharmaceutical Tigecycline Product Portfolio
- 4.2.5 Sino Biopharmaceutical Recent Developments
- 4.3 Zhejiang Hisun Pharma
- 4.3.1 Zhejiang Hisun Pharma Company Information
- 4.3.2 Zhejiang Hisun Pharma Business Overview
- 4.3.3 Zhejiang Hisun Pharma Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Zhejiang Hisun Pharma Tigecycline Product Portfolio
- 4.3.5 Zhejiang Hisun Pharma Recent Developments
- 4.4 Jiangsu Hansoh Pharmaceutical
- 4.4.1 Jiangsu Hansoh Pharmaceutical Company Information
- 4.4.2 Jiangsu Hansoh Pharmaceutical Business Overview
- 4.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jiangsu Hansoh Pharmaceutical Tigecycline Product Portfolio
- 4.4.5 Jiangsu Hansoh Pharmaceutical Recent Developments
- 4.5 Abbott
- 4.5.1 Abbott Company Information
- 4.5.2 Abbott Business Overview
- 4.5.3 Abbott Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Abbott Tigecycline Product Portfolio
- 4.5.5 Abbott Recent Developments
- 4.6 Natco Pharma
- 4.6.1 Natco Pharma Company Information
- 4.6.2 Natco Pharma Business Overview
- 4.6.3 Natco Pharma Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Natco Pharma Tigecycline Product Portfolio
- 4.6.5 Natco Pharma Recent Developments
- 4.7 Lyka Labs Limited
- 4.7.1 Lyka Labs Limited Company Information
- 4.7.2 Lyka Labs Limited Business Overview
- 4.7.3 Lyka Labs Limited Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lyka Labs Limited Tigecycline Product Portfolio
- 4.7.5 Lyka Labs Limited Recent Developments
- 4.8 Fresenius Kabi
- 4.8.1 Fresenius Kabi Company Information
- 4.8.2 Fresenius Kabi Business Overview
- 4.8.3 Fresenius Kabi Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Fresenius Kabi Tigecycline Product Portfolio
- 4.8.5 Fresenius Kabi Recent Developments
- 4.9 Sandoz
- 4.9.1 Sandoz Company Information
- 4.9.2 Sandoz Business Overview
- 4.9.3 Sandoz Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sandoz Tigecycline Product Portfolio
- 4.9.5 Sandoz Recent Developments
- 4.10 APOTEX
- 4.10.1 APOTEX Company Information
- 4.10.2 APOTEX Business Overview
- 4.10.3 APOTEX Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 APOTEX Tigecycline Product Portfolio
- 4.10.5 APOTEX Recent Developments
- 4.11 Accord Healthcare
- 4.11.1 Accord Healthcare Company Information
- 4.11.2 Accord Healthcare Business Overview
- 4.11.3 Accord Healthcare Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Accord Healthcare Tigecycline Product Portfolio
- 4.11.5 Accord Healthcare Recent Developments
- 4.12 Amneal Pharmaceuticals
- 4.12.1 Amneal Pharmaceuticals Company Information
- 4.12.2 Amneal Pharmaceuticals Business Overview
- 4.12.3 Amneal Pharmaceuticals Tigecycline Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Amneal Pharmaceuticals Tigecycline Product Portfolio
- 4.12.5 Amneal Pharmaceuticals Recent Developments
5 Global Tigecycline Market Scenario by Region
- 5.1 Global Tigecycline Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tigecycline Sales by Region: 2021-2032
- 5.2.1 Global Tigecycline Sales by Region: 2021-2026
- 5.2.2 Global Tigecycline Sales by Region: 2027-2032
- 5.3 Global Tigecycline Revenue by Region: 2021-2032
- 5.3.1 Global Tigecycline Revenue by Region: 2021-2026
- 5.3.2 Global Tigecycline Revenue by Region: 2027-2032
- 5.4 North America Tigecycline Market Facts & Figures by Country
- 5.4.1 North America Tigecycline Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tigecycline Sales by Country (2021-2032)
- 5.4.3 North America Tigecycline Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Tigecycline Market Facts & Figures by Country
- 5.5.1 Europe Tigecycline Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tigecycline Sales by Country (2021-2032)
- 5.5.3 Europe Tigecycline Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Tigecycline Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tigecycline Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tigecycline Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tigecycline Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tigecycline Market Facts & Figures by Country
- 5.7.1 South America Tigecycline Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tigecycline Sales by Country (2021-2032)
- 5.7.3 South America Tigecycline Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Tigecycline Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tigecycline Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tigecycline Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tigecycline Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Tigecycline Sales by Type (2021-2032)
- 6.1.1 Global Tigecycline Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Tigecycline Sales Market Share by Type (2021-2032)
- 6.2 Global Tigecycline Revenue by Type (2021-2032)
- 6.2.1 Global Tigecycline Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tigecycline Revenue Market Share by Type (2021-2032)
- 6.3 Global Tigecycline Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tigecycline Sales by Application (2021-2032)
- 7.1.1 Global Tigecycline Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Tigecycline Sales Market Share by Application (2021-2032)
- 7.2 Global Tigecycline Revenue by Application (2021-2032)
- 7.2.1 Global Tigecycline Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tigecycline Revenue Market Share by Application (2021-2032)
- 7.3 Global Tigecycline Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tigecycline Value Chain Analysis
- 8.1.1 Tigecycline Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tigecycline Production Mode & Process
- 8.2 Tigecycline Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tigecycline Distributors
- 8.2.3 Tigecycline Customers
9 Global Tigecycline Analyzing Market Dynamics
- 9.1 Tigecycline Industry Trends
- 9.2 Tigecycline Industry Drivers
- 9.3 Tigecycline Industry Opportunities and Challenges
- 9.4 Tigecycline Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst